Moderna, Inc. reports $1.94 billion revenue for fiscal year ended December 31, 2025, down 39.9%
Moderna, Inc. reported revenue of $1.94 billion for the year ended December 31, 2025, a decrease of 39.9% from the previous year ($3.24 billion).
For the same period it posted a net loss of $2.82 billion, or $-7.26 per diluted share (-9.28 a year earlier).
That is a net margin of -145.2%.
On Sanad's AAOIFI Standard 21 screen, Moderna, Inc. is currently not compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 16.2% of revenue (limit 5%).
Is Moderna, Inc. halal?
See the full AAOIFI screening of Moderna, Inc.
See the full AAOIFI screening of Moderna, Inc.
Source: 10-K filed with the U.S. Securities and Exchange Commission on February 20, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.